ClinicalTrials.Veeva

Menu

VAC-Stent Registry

M

Markus M. Heiss

Status

Enrolling

Conditions

Perforation of the Oesophagus
Perforation of the Colon

Treatments

Device: VAC-Stent®

Study type

Observational

Funder types

Other

Identifiers

NCT04884334
VAC-Stent Registry

Details and patient eligibility

About

This registry is intended to collect data on quality assurance and use of the VAC-Stent® and thus verify the suitability of the VAC-Stent® for sealing leakages in the oesophagus or colon. Furthermore, the safety and efficacy of the VAC-Stent® shall be proven.

Full description

For this registry, quality assurance data will be prospectively collected from all patients who receive the VAC-Stent®. The VAC-Stent® combines a vacuum sponge, which lies intraluminal and conditions the wound, with a covered stent, which seals the sponge from the lumen and thus ensures passage. Due to its design, the new medical device VAC-Stent® offers a solution for the most important problems of the covered stent, the stent migration and the lack of drainage function, as well as for those of the endoluminal vacuum sponge, the blockage of the gastrointestinal lumen and the difficult application. The VAC-Stent® is the technical advancement for all indications of the covered stent and for the indication of the endoluminal vacuum sponge, so that a very good effectiveness with reduced complications can be expected for these clinical situations.

The VAC-Stent® therefore offers the prospect of an innovative further development in the endoscopic treatment of leaks in the gastrointestinal tract, without any new and unknown risks being associated with it.

The primary aim of this registry is to collect data on the quality assurance and application of the VAC-Stent® and thus to evaluate the suitability of the VAC-Stent® for sealing leaks in the oesophagus or colon. In addition, the safety and efficacy of the VAC-Stent® will be demonstrated.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • written informed consent
  • treatment with the VAC-Stent®

Exclusion criteria

  • accommodation in an institution under court or administrative order

Trial design

200 participants in 1 patient group

VAC-Stent® treatment
Description:
spontaneous, iatrogenic or postoperative leakage of the oesophagus or colon
Treatment:
Device: VAC-Stent®

Trial contacts and locations

14

Loading...

Central trial contact

Markus M Heiss, Prof Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems